Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Routbort

Showing results (111-120 of 175) with videos related to

Pageof 18
Sort By:
The Journal of Molecular Diagnostics : JMD|December 23, 2018
Ultra-Rapid Reporting of GENomic Targets (URGENTseq): Clinical Next-Generation Sequencing Results within 48 Hours of Sample CollectionKeyur P Patel, Roberto Ruiz-Cordero, Wei Chen, et al.
JCO Precision Oncology|February 1, 2022
Validation of <i>HER2</i> Amplification as a Predictive Biomarker for Anti-Epidermal Growth Factor Receptor Antibody Therapy in Metastatic Colorectal CancerKanwal Raghav, Jonathan M Loree, Jeffrey S Morris, et al.
Leukemia Research|April 17, 2022
Landscape of NOTCH1 mutations and co-occurring biomarker alterations in chronic lymphocytic leukemiaFatima Zahra Jelloul, Richard Yang, Sofia Garces, et al.
Cancer|June 23, 2021
Only SF3B1 mutation involving K700E independently predicts overall survival in myelodysplastic syndromesRashmi Kanagal-Shamanna, Guillermo Montalban-Bravo, Koji Sasaki, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|October 6, 2020
A Cryptic BCR-PDGFRB Fusion Resulting in a Chronic Myeloid Neoplasm With Monocytosis and Eosinophilia: A Novel Finding With Treatment ImplicationsSanjeev Kumar Gupta, Nitin Jain, Guilin Tang, et al.
Haematologica|November 20, 2023
<i>STAT5B</i> mutations in myeloid neoplasms differ by disease subtypes but characterize a subset of chronic myeloid neoplasms with eosinophilia and/or basophiliaC Cameron Yin, Wayne Tam, Serena M Walker, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|June 11, 2022
Clinicopathologic spectrum of myeloid neoplasms with concurrent myeloproliferative neoplasm driver mutations and SRSF2 mutationsMehrnoosh Tashakori, Joseph D Khoury, Mark J Routbort, et al.
JCO Precision Oncology|October 16, 2018
Clinical Use of Precision Oncology Decision SupportAmber Johnson, Yekaterina B Khotskaya, Lauren Brusco, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 28, 2015
Feasibility of Large-Scale Genomic Testing to Facilitate Enrollment Onto Genomically Matched Clinical TrialsFunda Meric-Bernstam, Lauren Brusco, Kenna Shaw, et al.
JCO Precision Oncology|August 17, 2022
Impact of Somatic Mutations on Survival Outcomes in Patients With Anaplastic Thyroid CarcinomaJennifer Rui Wang, Matthew Montierth, Li Xu, et al.
Pageof 18

Showing results (111-120 of 175) with videos related to

Sort By:
Pageof 18
The Journal of Molecular Diagnostics : JMD|December 23, 2018
Ultra-Rapid Reporting of GENomic Targets (URGENTseq): Clinical Next-Generation Sequencing Results within 48 Hours of Sample CollectionKeyur P Patel, Roberto Ruiz-Cordero, Wei Chen, et al.
JCO Precision Oncology|February 1, 2022
Validation of <i>HER2</i> Amplification as a Predictive Biomarker for Anti-Epidermal Growth Factor Receptor Antibody Therapy in Metastatic Colorectal CancerKanwal Raghav, Jonathan M Loree, Jeffrey S Morris, et al.
Leukemia Research|April 17, 2022
Landscape of NOTCH1 mutations and co-occurring biomarker alterations in chronic lymphocytic leukemiaFatima Zahra Jelloul, Richard Yang, Sofia Garces, et al.
Cancer|June 23, 2021
Only SF3B1 mutation involving K700E independently predicts overall survival in myelodysplastic syndromesRashmi Kanagal-Shamanna, Guillermo Montalban-Bravo, Koji Sasaki, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|October 6, 2020
A Cryptic BCR-PDGFRB Fusion Resulting in a Chronic Myeloid Neoplasm With Monocytosis and Eosinophilia: A Novel Finding With Treatment ImplicationsSanjeev Kumar Gupta, Nitin Jain, Guilin Tang, et al.
Haematologica|November 20, 2023
<i>STAT5B</i> mutations in myeloid neoplasms differ by disease subtypes but characterize a subset of chronic myeloid neoplasms with eosinophilia and/or basophiliaC Cameron Yin, Wayne Tam, Serena M Walker, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|June 11, 2022
Clinicopathologic spectrum of myeloid neoplasms with concurrent myeloproliferative neoplasm driver mutations and SRSF2 mutationsMehrnoosh Tashakori, Joseph D Khoury, Mark J Routbort, et al.
JCO Precision Oncology|October 16, 2018
Clinical Use of Precision Oncology Decision SupportAmber Johnson, Yekaterina B Khotskaya, Lauren Brusco, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 28, 2015
Feasibility of Large-Scale Genomic Testing to Facilitate Enrollment Onto Genomically Matched Clinical TrialsFunda Meric-Bernstam, Lauren Brusco, Kenna Shaw, et al.
JCO Precision Oncology|August 17, 2022
Impact of Somatic Mutations on Survival Outcomes in Patients With Anaplastic Thyroid CarcinomaJennifer Rui Wang, Matthew Montierth, Li Xu, et al.
Pageof 18